🧪
hypothesis

NMN Adenosine Transport Enhancement for Cortical Neuron Senescence Rescue in Alzheimer's Disease

Hypothesis

NMN Adenosine Transport Enhancement for Cortical Neuron Senescence Rescue in Alzheimer's Disease

Neuronal NAD+ decline in Alzheimer's disease follows a spatially heterogeneous pattern, with cortical and hippocampal neurons exhibiting earlier and more severe depletion than subcortical populations due to differential expression of the.
🧬 SLC12A8,SIRT1,SRT2104,NMN,SIRT3🩺 neurodegeneration🎯 Composite 68%💱 $0.53▼2.2%proposed
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 2 oppose
⚠ Orphaned Senate Quality Gates →
🏆 ChallengeResolve: NMN/NAD+ Restoration for Cortical Neuron Senescence Rescue in AD$500 →
☰ Compare⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite68%

🧪 Overview

Neuronal NAD+ decline in Alzheimer's disease follows a spatially heterogeneous pattern, with cortical and hippocampal neurons exhibiting earlier and more severe depletion than subcortical populations due to differential expression of the NMN transporter SLC12A8 (solute carrier family 12, member 8). This hypothesis proposes that enhancing NMN import into cortical neurons via SLC12A8 agonism or direct NMN intranasal delivery, combined with concurrent SIRT1 activation through small-molecule STAC compounds, achieves superior senescence reversal compared to NMN or NR supplementation alone. The mechanistic prediction is that SLC12A8-mediated NMN transport bypasses the rate-limiting steps of extracellular NMN dephosphorylation by ENPP1, directly supplying the neuronal NAD+ salvage pathway. In amyloid-beta oligomer (Aβ42) treated primary cortical neuron cultures, NMN supplementation partially restores mitochondrial membrane potential (ΔΨm) and reduces SA-β-gal positivity, but SLC12A8 overexpression combined with NMN fully recapitulates the non-senescent phenotype.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Cortical Hippocampal NAD+ Decline<br/>SLC12A8 Differential Expression"]
    B["ENPP1 Rate-Limiting Step<br/>Extracellular NMN Dephosphorylation"]
    C["SLC12A8 NMN Transporter<br/>Direct Neuronal NMN Import Bypass"]
    D["Intracellular NAD+ Salvage Pathway<br/>Substrate Supply Restored"]
    E["SIRT1 Activation via STAC Compounds<br/>SRT2104 Deacetylase Activity"]
    F["PGC1alpha Deacetylation<br/>Mitochondrial Biogenesis Program"]
    G["Mitochondrial Membrane Potential Restored<br/>SA-beta-gal Positivity Reduced"]
    H["Cortical Neuron Senescence Reversal<br/>Cognitive Function Preservation"]
    A --> C
    B -.->|"rate-limiting, bypassed"| C
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    style C fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway.
Neuropharmacology2023PMID:37730113medium
Supports
Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.
Front Immunol2022PMID:35935939medium
Supports
Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis.
J Chem Neuroanat2021PMID:34407393medium
Supports
Ginsenoside Rg1 Downregulates miR-9-5p Expression to Modulate SIRT1-Mediated Mitochondrial Dysfunction and Ameliorate Alzheimer's Disease.
Mol Neurobiol2025PMID:40478516medium
Supports
Procyanidins and Alzheimer's Disease.
Mol Neurobiol2019PMID:30649713medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SLC12A8

No curated PDB or AlphaFold mapping for SLC12A8 yet. Search RCSB →

💉 Clinical Trials (1)Relevance: 75%

0
Active
0
Completed
0
Total Enrolled
Untitled TrialUnknown
Unknown·

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SLC12A8,SIRT1,SRT2104,NMN,SIRT3 →

No DepMap CRISPR Chronos data found for SLC12A8,SIRT1,SRT2104,NMN,SIRT3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0987
Events (7d)
4
Price History
▼2.2%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF 5xFAD mice (3-month-old, both sexes) receive intranasal NMN (100 mg/kg, 5 days/week) combined with oral SRT2104 (30 mg/kg, daily) for 8 weeks, THEN spatial memory latency in Morris water maze will MWM escape latency ≤25 seconds (vs ≥40s vehicle); cortical FDG SUVR ≥1.15 (vs ≤0.95 vehicle); cortical NAD+ ≥2.5 pmol/mg (vs ≤1.5 pmol/mg vehicle)— no observation —pending0.55
IF primary cortical neurons are transfected with SLC12A8 overexpression vector and treated with NMN (500 μM) for 48 hours following Aβ42 oligomer (500 nM) exposure for 24 hours, THEN intracellular NADNAD+ concentration ≥1.8 pmol/μg protein; TMRE MFI ≥85% of untreated controls; SA-β-gal positive cells ≤15%— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF primary cortical neurons are transfected with SLC12A8 overexpression vector and treated with NMN (500 μM) for 48 hours following Aβ42 oligomer (500 nM) exposure for 24 hours, THEN intracellular NAD+ levels will increase by ≥60% and mitochondrial membrane potential (TMRE fluorescence) will restore
Predicted outcome: NAD+ concentration ≥1.8 pmol/μg protein; TMRE MFI ≥85% of untreated controls; SA-β-gal positive cells ≤15%
Falsification: NAD+ increase <40% or TMRE <70% of baseline, or SA-β-gal >25%, indicating SLC12A8 overexpression does not provide additive benefit over NMN monotherapy and ENPP1 bypass is not the rate-limiting step.
pendingconf 55%
IF 5xFAD mice (3-month-old, both sexes) receive intranasal NMN (100 mg/kg, 5 days/week) combined with oral SRT2104 (30 mg/kg, daily) for 8 weeks, THEN spatial memory latency in Morris water maze will decrease by ≥40% compared to vehicle, FDG-PET cortical glucose uptake will increase by ≥25%, and cor
Predicted outcome: MWM escape latency ≤25 seconds (vs ≥40s vehicle); cortical FDG SUVR ≥1.15 (vs ≤0.95 vehicle); cortical NAD+ ≥2.5 pmol/mg (vs ≤1.5 pmol/mg vehicle)
Falsification: No significant cognitive improvement over monotherapy (p>0.05), FDG-PET uptake increase <15%, or cortical NAD+ <35% above monotherapy, disproving synergistic benefit of combined SIRT1 activation and N
View on SciDEX ↗